Latest news with #RhythmTheater

Business Wire

The Future of AI & Electrophysiology Takes Center Stage at Heart Rhythm 2025 with Vektor Medical

SAN DIEGO--(BUSINESS WIRE)-- Vektor Medical, a leader in non-invasive, AI-powered arrhythmia analysis technology, will showcase its transformative vMap technology at Heart Rhythm 2025, taking place April 25–27 in San Diego. Through live demonstrations at adjacent booths (#1523 and #1622), scientific abstract presentations, and a highly anticipated Rhythm Theater session featuring leading electrophysiologists, Vektor will offer attendees a firsthand look at how vMap is being integrated into clinical workflows to support more informed, efficient, and effective ablation strategies. This unique, data-driven approach is helping EPs accelerate diagnosis, enhance procedural accuracy, and improve outcomes across the arrhythmia care spectrum. Share vMap is the only FDA-cleared, AI-based arrhythmia analysis solution that uses a standard 12-lead ECG to non-invasively localize arrhythmia sources, including both focal and fibrillation-type rhythms. This unique, data-driven approach is helping EPs accelerate diagnosis, enhance procedural accuracy, and improve outcomes across the arrhythmia care spectrum. Experience vMap in Action Visit Booths #1523 and #1622 (side-by-side) to explore how vMap is redefining arrhythmia source localization. See firsthand how physicians use the technology to improve outcomes, streamline workflows, and expand access to effective treatment. Schedule a one-on-one demo with the Vektor team here. Rhythm Theater Session 'AI and PFA: A Complementary Approach to Arrhythmia Treatment' Saturday, April 26 | 9:15 – 10:00 a.m. | Rhythm Theater 2 Moderated by Dr. Devi Nair, Director of Cardiac Electrophysiology at St. Bernards Heart & Vascular, this session will spotlight how AI-powered ECG analysis elevates the standard of care in EP labs. The panel will also explore how vMap integrates with pulsed field ablation (PFA) and other advanced treatment strategies. Panelists and discussion topics include: Dr. Gery Tomassoni, Baptist Health Lexington: Non-PV Driver Ablation with vMap and Upcoming Clinical Studies Dr. Benjamin D'Souza, Penn Medicine: vMap's Role in VT Ablation and Procedural Outcomes Dr. Anish Amin, OhioHealth: Integrating vMap into AF Ablation Procedures with PFA Scientific Abstract Presentations Mapping of Unstable Scar Mediated Ventricular Tachycardias: A Novel Technique Saturday, April 26 | 9:30 – 11:30 a.m. Dr. Faris Haddadin Abstract Pavilion Optimizing Procedural Techniques for Improved Ablation Outcomes Sunday, April 27 | 8:00 – 9:00 a.m. 'Prospective Non-Invasive Artificial Intelligence-Based CT and ECG Localization of Scar-Based Ventricular Arrhythmias' - Dr. Gordon Ho Oral Abstract Hub 1 – Sails Pavilion 'vMap addresses a critical gap in arrhythmia care,' said Rob Krummen, CEO of Vektor Medical. 'Electrophysiologists across the U.S. are using vMap to guide ablation strategies with greater confidence, and the results are gaining attention. At HRS, we are proud to showcase that impact through live demos and by amplifying the voices of the physicians using this technology every day. As we prepare to launch multiple key clinical studies, including our pivotal randomized trial, we are deepening the clinical foundation for broader adoption. This is a pivotal moment—for Vektor and the future of electrophysiology.' About vMap® vMap is the only FDA-cleared, non-invasive AI-powered solution for mapping arrhythmias, utilizing just a 12-lead ECG. vMap localizes arrhythmia sources for focal and fibrillatory arrhythmias, including atrial fibrillation. By unlocking actionable insights contained within a standard 12-lead ECG, vMap enables physicians to rapidly and accurately locate arrhythmia source locations. Backed by extensive clinical evidence, vMap not only improves patient outcomes but also reduces procedure time, optimizing workflow across the entire arrhythmia care pathway. About Vektor Medical Headquartered in San Diego, Vektor Medical is on a mission to revolutionize arrhythmia care for millions affected by atrial fibrillation and other arrhythmias. Through its AI-powered, non-invasive arrhythmia analysis technology, vMap, the company aims to improve cardiac ablation outcomes, optimize workflows, and increase procedural efficiency. For more information about vMap and Vektor Medical, please visit Connect with Vektor Medical on LinkedIn and X.